4-Methylpyrazole hydrochloride
SIGMA/M1387 - alcohol dehydrogenase inhibitor
Synonym: Fomepizole
CAS Number: 56010-88-9
Empirical Formula (Hill Notation): C4H6N2 · HCl
Molecular Weight: 118.56
MDL Number: MFCD00012707
Linear Formula: C4H6N2 · HCl
Product Type: Chemical
| assay | ≥95% |
| biological source | synthetic (organic) |
| form | powder |
| InChI | 1S/C4H6N2.ClH/c1-4-2-5-6- |
| InChI key | PUCXJHNDMYZOHG-UHFFFAOYSA |
| mp | 157-159 °C |
| Quality Level | 200 ![]() |
| SMILES string | Cl.Cc1cn[nH]c1 |
| solubility | methanol: 100 mg/mL, clear, colorless to yellow |
| storage temp. | 2-8°C |
| Application: | 4-Methylpyrazole hydrochloride has been used: • as a cytochrome P450 2E1 inhibitor • as cytochrome P450 2E1 and alcohol dehydrogenase inhibitor in 1C11 neural progenitor cells • to inhibit ethanol oxidation in VL-17A cells expressing alcohol dehydrogenase and HepG2 cells |
| Application: | Useful as an antidote in methanol and ethylene glycol poisoning. |
| Biochem/physiol Actions: | 4-Methylpyrazole (4MP) inhibits ethanol oxidation in liver microsomes. It also blocks the c-Jun N-terminal kinase (JNK) activation in in vitro liver injury models. |
| Biochem/physiol Actions: | Alcohol dehydrogenase inhibitor |
| Packaging: | 1 g in poly bottle |
| Packaging: | 100, 500 mg in poly bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H315 - H319 - H335 |
| Precautionary statements | P302 + P352 - P305 + P351 + P338 |
| Hazard Codes | Xi |
| Risk Statements | 36/37/38 |
| Safety Statements | 26-36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥95% |
| mp | 157-159 °C |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352202 |


